or Try an Advanced Search...

    Technical Analysis for CLSD - Clearside Biomedical, Inc.

    Grade Last Price % Change Price Change
    D 1.24 -4.62% -0.06
    CLSD closed down 4.62 percent on Monday, July 1, 2024, on 41 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Up
    Historical CLSD trend table...
    Date Alert Name Type % Chg
    Fell Below 50 DMA Bearish 0.00%
    Overbought Stochastic Strength 0.00%
    50 DMA Support Bullish -4.62%
    NR7 Range Contraction -4.62%
    NR7-2 Range Contraction -4.62%
    Overbought Stochastic Strength -4.62%
    Crossed Above 20 DMA Bullish -3.13%
    Crossed Above 50 DMA Bullish -3.13%
    NR7 Range Contraction -3.13%
    Stochastic Reached Overbought Strength -3.13%
    Older End-of-Day Signals for CLSD ...

       Recent Intraday Alerts

    Alert Time
    Down 5% about 8 hours ago
    60 Minute Opening Range Breakdown about 8 hours ago
    Fell Below Previous Day's Low about 9 hours ago
    Down 3% about 10 hours ago
    50 DMA Resistance about 10 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    CLSD Chart by TradingView
    Basic chart:

    Profile

    Clearside BioMedical, Inc., a biopharmaceutical company, develops drug therapies to treat chronic blinding diseases of the eye. Its products include CLS-1001 for the treatment of macular edema associated with non-infectious uveitis; CLS-1003 for the treatment of macular edema associated with retinal vein occlusion; and CLS-1002 program for the treatment of wet age-related macular degeneration. The company was founded in 2011 and is headquartered in Alpharetta, Georgia.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biopharmaceutical Eye Ophthalmology Macular Degeneration Macular Edema Retina Veins Wet Age Related Macular Degeneration Drug Therapies Uveitis Adverum Biotechnologies Non Infectious Uveitis Retinal Vein Occlusion

    Is CLSD a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 27 Clearside Biomedical to Host Virtual Key Opinion Leader Event on the Use and Versatility of Suprachoroidal Drug Delivery
    Jun 12 Clearside Biomedical’s Leadership in Suprachoroidal Delivery Featured in Multiple Presentations at the Clinical Trials at the Summit Meeting
    Jun 3 Shareholders in Clearside Biomedical (NASDAQ:CLSD) are in the red if they invested three years ago
    May 21 Clearside Biomedical Announces Publication of Consensus Guidelines for Drug Delivery via Suprachoroidal Space (SCS®) Injection in Leading Peer-Reviewed Industry Journal, RETINA®
    May 16 Clearside Biomedical And 3 Other Penny Stocks Insiders Are Buying
    May 10 Q1 2024 Clearside Biomedical Inc Earnings Call
    May 10 Clearside Biomedical, Inc. (NASDAQ:CLSD) Q1 2024 Earnings Call Transcript
    May 10 Clearside Biomedical, Inc. (CLSD) Q1 2024 Earnings Call Transcript
    May 9 Clearside Biomedical, Inc. (CLSD) Reports Q1 Loss, Misses Revenue Estimates
    May 9 Clearside Biomedical GAAP EPS of -$0.17 misses by $0.03, revenue of $0.23M misses by $0.45M
    See more CLSD news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 2.12
    52 Week Low 0.6501
    Average Volume 191,510
    200-Day Moving Average 1.20
    50-Day Moving Average 1.28
    20-Day Moving Average 1.21
    10-Day Moving Average 1.19
    Average True Range 0.10
    RSI (14) 50.00
    ADX 18.43
    +DI 17.44
    -DI 19.78
    Chandelier Exit (Long, 3 ATRs) 1.16
    Chandelier Exit (Short, 3 ATRs) 1.29
    Upper Bollinger Bands 1.33
    Lower Bollinger Band 1.09
    Percent B (%b) 0.63
    BandWidth 20.25
    MACD Line -0.02
    MACD Signal Line -0.03
    MACD Histogram 0.015
    Fundamentals Value
    Market Cap 78.88 Million
    Num Shares 63.6 Million
    EPS -0.61
    Price-to-Earnings (P/E) Ratio -2.03
    Price-to-Sales 40.85
    Price-to-Book 3.93
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.36
    Resistance 3 (R3) 1.36 1.33 1.34
    Resistance 2 (R2) 1.33 1.30 1.33 1.33
    Resistance 1 (R1) 1.28 1.28 1.27 1.28 1.33
    Pivot Point 1.25 1.25 1.24 1.24 1.25
    Support 1 (S1) 1.20 1.22 1.18 1.20 1.15
    Support 2 (S2) 1.17 1.20 1.16 1.15
    Support 3 (S3) 1.12 1.17 1.14
    Support 4 (S4) 1.12